We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
-3.83%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$708M
AUM Growth
-$202M
Cap. Flow
-$206M
Cap. Flow %
-29.05%
Top 10 Hldgs %
51.4%
Holding
107
New
17
Increased
18
Reduced
23
Closed
41

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$24.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$23.8M
3
PFE icon
Pfizer
PFE
+$14.9M
4
AMD icon
Advanced Micro Devices
AMD
+$11.9M
5
ZIM icon
ZIM Integrated Shipping Services
ZIM
+$10.2M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$39.7M
2
LLY icon
Eli Lilly
LLY
+$23M
3
MSFT icon
Microsoft
MSFT
+$17M
4
AMZN icon
Amazon
AMZN
+$14M
5
META icon
Meta Platforms (Facebook)
META
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 72.1%
2 Miscellaneous 16.41%
3 Industrials 4.53%
4 Technology 3.78%
5 Financials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPX icon
76
Compass Therapeutics
CMPX
$339M
– –
-700,000
Closed -$2.22M
DYN icon
77
Dyne Therapeutics
DYN
$3.34B
– –
-105,204
Closed -$1.25M
EPIX
78
DELISTED
ESSA Pharma
EPIX
– –
-422,461
Closed -$6M
IDYA icon
79
IDEAYA Biosciences
IDYA
$3.76B
– –
-235,695
Closed -$5.57M
IOVA icon
80
Iovance Biotherapeutics
IOVA
$4.64B
– –
-281,769
Closed -$5.38M
KALV
81
DELISTED
KalVista Pharmaceuticals
KALV
– –
-316,200
Closed -$4.18M
LESL icon
82
Leslie's
LESL
$4.2M
– –
-18,628
Closed -$8.81M
LVTX
83
DELISTED
LAVA Therapeutics
LVTX
– –
-137,857
Closed -$758K
META icon
84
Meta Platforms (Facebook)
META
$1.72T
– –
-41,622
Closed -$14M
MSFT icon
85
Microsoft
MSFT
$3.68T
– –
-50,536
Closed -$17M
PANW icon
86
Palo Alto Networks
PANW
$308B
– –
-144,000
Closed -$13.4M
PMVP icon
87
PMV Pharmaceuticals
PMVP
$77.5M
– –
-190,525
Closed -$4.4M
PTGX icon
88
CALL
Protagonist Therapeutics
PTGX
$9.27B
– –
-250,000
Closed -$8.55M
QURE icon
89
CALL
uniQure
QURE
$3.06B
– –
-100,000
Closed -$2.07M
STRO icon
90
Sutro Biopharma
STRO
$255M
– –
-28,170
Closed -$4.19M
VRNT
91
DELISTED
Verint Systems
VRNT
– –
-200,000
Closed -$10.5M
VRTX icon
92
Vertex Pharmaceuticals
VRTX
$130B
– –
-4,411
Closed -$969K
XBI icon
93
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.6B
– –
-220,000
Closed -$24.6M
ZLAB icon
94
Zai Lab
ZLAB
$2.9B
– –
-111,641
Closed -$7.02M
LENZ
95
LENZ Therapeutics
LENZ
$126M
– –
-94,742
Closed -$8.24M
OMGA
96
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-352,948
Closed -$4M
ARYD
97
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
– –
-1,000,000
Closed -$9.93M
CYT
98
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
– –
-98,860
Closed -$1.12M
PNT
99
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-592,592
Closed -$3.32M
ARYE
100
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
– –
-200,000
Closed -$1.94M
1 2 3
4
5

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sphera Funds Management held 107 positions worth $708M, down 22% from $910M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sphera Funds Management withdrew a net $206M in Q1 2022, closing 41 positions and reducing 23 holdings. Its most notable exit was Microsoft, an estimated $17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 68% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Sphera Funds Management opened a new position in Novo Nordisk worth $26.4M.

  • Sphera Funds Management's largest Q1 2022 buy was Novo Nordisk: 474,800 shares worth $26.4M.
  • Sphera Funds Management added most to Johnson & Johnson in Q1 2022, an estimated $23.8M increase.
  • Sphera Funds Management's biggest Q1 2022 reduction was AbbVie, cutting an estimated $39.7M.
  • Sphera Funds Management fully exited Microsoft in Q1 2022, selling an estimated $17M.
  • Sphera Funds Management's ten largest holdings make up 51% of its $708M portfolio in Q1 2022.
  • Sphera Funds Management opened 17 new positions and closed 41 in Q1 2022.
  • Sphera Funds Management's portfolio value fell 22% quarter-over-quarter to $708M.

Based on Sphera Funds Management's 13F filing for Q1 2022, filed 16 May 2022.